MPLT - Company ID 0001770069
MapLight Therapeutics, Inc. trades as MPLT and has a market capitalization of $1.80 B, making it the #2227 largest US-listed company by market value. This page tracks MapLight Therapeutics, Inc. through 144 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
The largest companies sharing MapLight Therapeutics, Inc.'s SEC industry classification (pharmaceutical preparations).
MapLight Therapeutics, Inc. (MPLT) has a market capitalization of $1.80 B as of 2026-07-09, ranking #2227 among US-listed companies.
In its latest fiscal year MapLight Therapeutics, Inc. reported a net loss of $161.15M.